Sanatra Pharma Private Limited
About Sanatra Pharma Private Limited
Data last updated:
Sanatra Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2013PTC191679.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Sontosh Dey and Montosh Dey.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Ground Floor Block C Swagat Chinar Park Tegharia, Kolkata, West Bengal, India – 700059.
As per the financials filed for FY 2022, the company reported a revenue of ₹22,500, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹148 (net margin 0.7%) and EBITDA of ₹200 (EBITDA margin 0.9%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sanatra Pharma Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGround Floor Block C Swagat Chinar Park Tegharia, Kolkata, West Bengal, India – 700059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanatra Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sanatra Pharma Private Limited
FY 2022 filings availableSanatra Pharma Private Limited reported revenue of ₹22,500 (down 6% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 6% fall in the latest year. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹22,500 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹200 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹148 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanatra Pharma Private Limited, buy the company report.
Board of directors of Sanatra Pharma Private Limited
Sanatra Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sontosh Dey | Director | 02 Apr 2013 | 13 Years 6 Months | Current |
| Montosh Dey | Director | 02 Apr 2013 | 13 Years 6 Months | Current |
Auditor
Sanatra Pharma Private Limited is audited by A K DHANDHANIA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A K DHANDHANIA & ASSOCIATES | FY 2022 | 324620E |
Shareholding
The shareholding of Sanatra Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanatra Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanatra Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanatra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanatra Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanatra Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Montosh Dey was appointed as Director on 02 Apr 2013.
Frequently asked questions
Sanatra Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 2013 (13+ years old) and is registered under CIN U74900WB2013PTC191679.
Sanatra Pharma has 2 current directors:
- Sontosh Dey - Director
- Montosh Dey - Director
The latest financial statements of Sanatra Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sanatra Pharma is U74900WB2013PTC191679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanatra Pharma was incorporated on 02 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
Montosh Dey was appointed as Director on 02 Apr 2013. Sontosh Dey was appointed as Director on 02 Apr 2013.
The registered office of Sanatra Pharma is at Ground Floor Block C Swagat Chinar Park Tegharia, Kolkata, West Bengal, India – 700059.
Sanatra Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sanatra Pharma is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sanatra Pharma can be reached at its registered office: Ground Floor Block C Swagat Chinar Park Tegharia, Kolkata, West Bengal, India – 700059.